Neuromod Devices Limited: FDA filings under this applicant name
FDA lists 0 510(k) clearances under the applicant name “Neuromod Devices Limited”, plus 1 De Novo decision, across 1 product code in 1 review panel. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| QVN | Combined Acoustic And Electrical External Stimulation Device For The Relief Of Tinnitus | 1 | 0 |
Review panels
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN210033 | De Novo | Combined Acoustic And Electrical External Stimulation Device For The Relief Of Tinnitus | 2023-03-06 |
Recalls
openFDA lists no recalls under a recalling firm named Neuromod Devices Limited.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Frequently asked questions
How many FDA 510(k) clearances are listed under Neuromod Devices Limited?
FDA lists 0 510(k) clearances under the applicant name “Neuromod Devices Limited”, plus 1 De Novo decision, across 1 product code in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
Which FDA product codes appear under Neuromod Devices Limited?
The most frequent FDA product codes under this applicant name are QVN (Combined Acoustic And Electrical External Stimulation Device For The Relief Of Tinnitus, 1).
Next steps
- See all 0 Neuromod Devices Limited clearances with predicates and recalls
- Run predicate analysis for product code QVN, Neuromod Devices Limited's most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.